SCHEMBL12900254

SCHEMBL12900254

Cc1cccc2c(Br)c[nH]c12

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ TRIM24 O15164 1/20 0.55
▸ TRIM33 Q9UPN9 1/20 0.55
▸ BRPF1 P55201 1/20 0.53
▸ AR P10275 6/20 0.53
▸ HTR2A P28223 1/20 0.51
▸ MAPT P10636 1/20 0.50
▸ SMN1; SMN2 Q16637 1/20 0.50
▸ NPSR1 Q6W5P4 1/20 0.50
▸ NR4A2 P43354 1/20 0.49
▸ SOS2 Q07890 1/20 0.49
▸ AHR P35869 1/20 0.44
▸ KIF11 P52732 1/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ CYP2A6 P11509 1/20 0.42
▸ DYRK1A Q13627 1/20 0.42
▸ AXL P30530 1/20 0.41
▸ PCSK9 Q8NBP7 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30963689 1.00 TRIM24 (0.55) TRIM24TRIM33BRPF1ARHTR2A
SCHEMBL2143637 0.80 TRIM24 (0.60) TRIM24TRIM33BRPF1ARHTR2A
SCHEMBL31607554 0.80 TRIM24 (0.60) TRIM24TRIM33BRPF1ARHTR2A
SCHEMBL31302783 0.75 TRIM24 (0.55) TRIM24TRIM33BRPF1ARHTR2A
SCHEMBL19518384 0.75 TRIM24 (0.55) TRIM24TRIM33BRPF1ARHTR2A
SCHEMBL21623871 0.75 BRPF1 (0.58) TRIM24TRIM33BRPF1ARHTR2A
SCHEMBL17150712 0.75 TRIM24 (0.55) TRIM24TRIM33BRPF1ARHTR2A
SCHEMBL12865280 0.75 TRIM24 (0.55) TRIM24TRIM33BRPF1ARHTR2A
SCHEMBL31049280 0.75 HTR2A (0.56) TRIM24TRIM33BRPF1ARHTR2A
SCHEMBL23658612 0.75 GPR84 (0.58) DYRK1AAXLPCSK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110028463-A1 AMIDE COMPOUNDS ASTELLAS PHARMA INC. (JP) 2011-02-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110028463-A1 AMIDE COMPOUNDS PTGER4, PTGER1, PTGER2 TRIM24 3869/4885TRIM33 4121/4885BRPF1 883/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback